NewYork–Presbyterian Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

    Leukemia, Vol. 34, Núm. 8, pp. 2125-2137